National Immunization Programme – Mission Indradhanush Programme: Newer Approaches and Interventions

  • Ajeet Singh BhadoriaEmail author
  • Surabhi Mishra
  • Mahendra Singh
  • Surekha Kishore
Review Article


Vaccines are globally accepted as instrumental in drastically bringing down vaccine preventable diseases (VPDs) related mortality and morbidity. Despite global relentless efforts, about 19.3 million children still go missing for full immunization and are at risk for VPDs. Government of India has tried to rejuvenate its four decades old Universal Immunization Programme (UIP) by recently launching Mission Indradhanush in 2014, followed by Intensified Mission Indradhanush in 2017 to boost up immunization coverage. UIP have also brought in newer vaccines, changed dose schedules, open vial policy and a robust surveillance system. Even then, country’s average immunization coverage is much below par. Thus, there is a pressing need for transforming immunization program from simple vaccine delivery platform to a comprehensive disease control programme. Country should introduce newer vaccines through evidence-based policies and increase access to immunization services through system strengthening.


Immunization Vaccines Mission Indradhanush Universal immunization programme 


Authors’ Contributions

All authors have contributed equally from inception to finalization of manuscript. ASB will act as guarantor for this paper.

Compliance with Ethical Standards

Conflict of Interest


Source of Funding



  1. 1.
    Government of India. Immunization Handbook for Medical Officers. Ministry of Health and Family Welfare. New Delhi. 2017. Available at: Accessed 04 Aug 2018.
  2. 2.
    Okwo-Bele. WHO | Together we can close the immunization gap. [Internet].2015 April 22 . Available at: Accessed 25 Oct 2018.
  3. 3.
    Centre for Disease Control and Prevention (CDC). Global routine vaccination Coverage.2010. MMWR Morb Mortal Wkly Rep. 2011;60:1520–2.Google Scholar
  4. 4.
    National Family Health Survey (NFHS-4), 2015–16 India. Mumbai, India: International Institute for Population Sciences (IIPS). Mumbai. 2017. Available at: Accessed 04 Aug 2018.
  5. 5.
    Kusuma YS, Kumari R, Pandav CS, Gupta SK. Migration and immunization: determinants of childhood immunization uptake among socioeconomically disadvantaged migrants in Delhi, India. Tropical Med Int Health. 2010;15:1326–32.CrossRefGoogle Scholar
  6. 6.
    Union Government launched health mission – ‘Mission Indradhanush’ New Delhi: India Today, 26 Dec 2014. Available at: Accessed 4 Aug 2018.
  7. 7.
    Government of India. Intensified Mission Indradhanush: Operational Guidelines. Ministry of Health and Family Welfare, 2018.Google Scholar
  8. 8.
    Government of India. Mission Indradhanush: Operational Guidelines. Ministry of Health and Family Welfare, 2016Google Scholar
  9. 9.
    Press Information Bureau. Health Ministry to launch Intensified Mission Indradhanush : Targets full immunization coverage by 2018. Government of India. Ministry of Health and Family Welfare. Available at: Accessed 4 Aug 2018.
  10. 10.
    Rammohan A, Awofeso N. District-level variations in childhood immunizations in India: the role of socio-economic factors and health infrastructure. Soc Sci Med. 2015;145:163–72.CrossRefGoogle Scholar
  11. 11.
    Singh PK. Trends in child immunization across geographical regions in India: focus on urban-rural and gender differentials. PLoS One. 2013;8:e73102.CrossRefGoogle Scholar
  12. 12.
    John TJ. World immunization week 2018: what lessons for India? Indian J Med Res. 2018;147:330–3.CrossRefGoogle Scholar
  13. 13.
    Mahajan A. Is this philanthropy or just business? The Statesman. 2016 Mar 31. Available at: Accessed 06 Sept 2016.
  14. 14.
    Government of India. Operational Guidelines. Introduction of rotavirus vaccine in the universal immunization Programme in India. Immunization division. In: Ministry of health and family welfare; 2016.Google Scholar
  15. 15.
    Puliyel JM, Mathew JL. Should India launch a national immunization programme against rotavirus? No. BMJ. 2012;345:e7832.CrossRefGoogle Scholar
  16. 16.
    Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615–23.CrossRefGoogle Scholar
  17. 17.
    Lodha R, Shah D. Prevention of rotavirus diarrhea in India: is vaccination the only strategy. Indian Pediatr. 2012;49:441–3.Google Scholar
  18. 18.
    Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics. 2010;4:213–29.Google Scholar
  19. 19.
    Farooqui H, Jit M, Heymann DL, Zodpey S. Burden of severe pneumonia, pneumococcal pneumonia and pneumonia deaths in Indian states: modelling based estimates. PLoS One. 2015;10:e0129191.CrossRefGoogle Scholar
  20. 20.
    Press Information Bureau. Government of India. Ministry of Health and Family Welfare. Shri J P Nadda launches Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Programme (UIP). Available at: Accessed 17 Aug 2018.
  21. 21.
    Vashishtha VM. Pneumococcal vaccines—the future. Indian J Pediatr. 2015;82:S55–60.Google Scholar
  22. 22.
    Glassman A, Cañón O, Silverman R. How to get cost-effectiveness analysis right? The case of vaccine economics in Latin America. Value Health. 2016;19:913–20.CrossRefGoogle Scholar
  23. 23.
    Megiddo I, Klein E, Laxminarayan R. Potential impact of introducing the pneumococcal conjugate vaccine into national immunization programmes: an economic-epidemiological analysis using data from India. BMJ Global Health. 2018;3:e000636.CrossRefGoogle Scholar
  24. 24.
    Kanungo R. Knowledge of serotype prevalence & burden of invasive pneumococcal disease: a prerequisite to vaccine introduction in the country. Indian J Med Res. 2015;142:241–4.CrossRefGoogle Scholar
  25. 25.
    Government of India. Operational Guidelines. Pentavalent Vaccine Introduction. In: Ministry of Health and Family Welfare and World Health Organization India; 2014.Google Scholar
  26. 26.
    Government of India. Immunization Handbook for Medical Officers in India. New Delhi: MoHFW, Govt. of India; 2008.Google Scholar
  27. 27.
    Puliyel J. AEFI and the pentavalent vaccine: looking for a composite picture. Indian J Med Ethics. 2013;10:142–6.Google Scholar
  28. 28.
    Kuensel Online, Bhutan’s daily news site [Internet]. Bhutan:Kuensel Online; c 2010–2013. Editorial The pentavalent vaccine pause; 2009 Oct 29;[about 2 screens]. Available at: Accessed 19 June 2013.
  29. 29.
    Saxena KB, Banerji D. Qadeer I, et al. “Antivaccine lobby”replies to the BMJ. BMJ 2010. 341:c4001.Google Scholar
  30. 30.
    Mittal SK. Antivaccine lobby resists introduction of Hib vaccine in India. BMJ[Internet]. 2010;340:c3508.Available at: Accessed 22 June 2013.
  31. 31.
    Firstpost.[Internet]. India. F wire. The unfortunate story of 37 deaths from a ‘good vaccine’ (Comment, Special to IANS); 2013 Oct 19. Available at: Accessed 24 Feb 2014.
  32. 32.
    World Health Organisation. [internet]. India: Ministry of Health and Family Welfare Government of India; Routine Immunization Pentavalent Vaccine, Guide for Health Workers with Answers to Frequently Asked Questions.2012. Available at: Accessed 24 Feb 2014.
  33. 33.
    Gupta SK, Sosler S, Lahariya C. Introduction of Haemophilus influenzae type b (Hib) as pentavalent (DPT-HepB-Hib) vaccine in two states of India. Indian Pediatr. 2012;49:707–9.CrossRefGoogle Scholar
  34. 34.
    Gavi, Alliance partnership strategy with India, 2016–2021. Available at: Accessed 4 Aug 2018.
  35. 35.
    Chatterjee S, Chattopadhyay A, Samanta L, Panigrahi P. HPV and cervical cancer epidemiology - current status of HPV vaccination in India. Asian Pac J Cancer Prev. 2016;17:3663–73.Google Scholar
  36. 36.
    Bloom DE, Canning D, Shenoy ES. The effect of vaccination on children’s physical and cognitive development in the Philippines. Appl Econ. 2012;44:2777–83.CrossRefGoogle Scholar
  37. 37.
    Nandi A, Barter DM, Prinja S, John TJ. The estimated health and economic benefits of three decades of polio elimination efforts in India. Indian Pediatr. 2016;53:S7–13.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  • Ajeet Singh Bhadoria
    • 1
    Email author
  • Surabhi Mishra
    • 1
  • Mahendra Singh
    • 1
  • Surekha Kishore
    • 1
  1. 1.Department of Community and Family MedicineAll India Institute of Medical SciencesRishikeshIndia

Personalised recommendations